Effects of 38C13 adenovirus vaccination on survival of tumor-challenged wild type or β2M-deficient mice.

Groups of wild type C3H mice were vaccinated with 10⁸ PFU Ad-IdhuCR (▴) (n = 10) or Ad-C6VL-TCR (▵) (n = 10) as a control. The β2M-deficient C3H mice were also vaccinated with Ad-IdhuCR (○) (n = 8). Three weeks later, mice were injected SQ with 1000 38C13 tumor cells and followed for survival.